Literature DB >> 30224534

Comparative Epidemiology of Vancomycin-Resistant Enterococci Colonization in an Acute-Care Hospital and Its Affiliated Intermediate- and Long-Term Care Facilities in Singapore.

Damon Tan1, Htet Lin Htun2, Jocelyn Koh3, Kala Kanagasabai4, Jia-Wei Lim2, Pei-Yun Hon2, Brenda Ang5, Angela Chow6.   

Abstract

Vancomycin-resistant enterococci (VRE) are an important cause of nosocomial infections in acute-care hospitals (ACHs), intermediate-care facilities (ITCFs), and long-term care facilities (LTCFs). This study contemporaneously compared the epidemiology and risk factors for VRE colonization in different care settings in a health care network. We conducted a serial cross-sectional study in a 1,700-bed ACH and its six closely affiliated ITCFs and LTCFs in June and July of 2014 to 2016. Rectal swab or stool specimens were cultured for VRE. Multivariable logistic regression was used to assess for independent risk factors associated with VRE colonization. Of 5,357 participants, 523 (9.8%) were VRE colonized. VRE prevalence was higher in ACHs (14.2%) than in ITCFs (7.6%) and LTCFs (0.8%). Common risk factors between ACHs and ITCFs included prior VRE carriage, a longer duration of antibiotic therapy, surgery in the preceding 90 days, and the presence of a skin ulcer. Independent risk factors specific to ACH-admitted patients were prior methicillin-resistant Staphylococcus aureus carriage, a higher number of beds per room, prior proton pump inhibitor use, and a length of stay of >14 days. For ITCFs, a length of stay of >14 days was inversely associated with VRE colonization. Similarities and differences in risk factors for VRE colonization were observed between health care settings. VRE prevention efforts should target the respective high-risk patients.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  acute-care hospital; epidemiology; intermediate-care facilities; long-term care facilities; vancomycin-resistant enterococci

Mesh:

Substances:

Year:  2018        PMID: 30224534      PMCID: PMC6256803          DOI: 10.1128/AAC.01507-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  48 in total

Review 1.  Spread of vancomycin-resistant enterococci: why did it happen in the United States?

Authors:  W J Martone
Journal:  Infect Control Hosp Epidemiol       Date:  1998-08       Impact factor: 3.254

2.  Epidemiology and molecular typing of VRE bloodstream isolates in an Irish tertiary care hospital.

Authors:  L Ryan; E O'Mahony; C Wrenn; S FitzGerald; U Fox; B Boyle; K Schaffer; G Werner; I Klare
Journal:  J Antimicrob Chemother       Date:  2015-07-04       Impact factor: 5.790

3.  A Successful Vancomycin-Resistant Enterococci Reduction Bundle at a Singapore Hospital.

Authors:  Dale Fisher; Long Pang; Sharon Salmon; Raymond T P Lin; Cathrine Teo; Paul Tambyah; Roland Jureen; Alex R Cook; Jonathan A Otter
Journal:  Infect Control Hosp Epidemiol       Date:  2015-10-21       Impact factor: 3.254

4.  Patients in long-term care facilities: a reservoir for vancomycin-resistant enterococci.

Authors:  Marnie L Elizaga; Robert A Weinstein; Mary K Hayden
Journal:  Clin Infect Dis       Date:  2002-01-07       Impact factor: 9.079

5.  Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study.

Authors:  Shelly A McNeil; Preeti N Malani; Carol E Chenoweth; Robert J Fontana; John C Magee; Jeffrey D Punch; Monica L Mackin; Carol A Kauffman
Journal:  Clin Infect Dis       Date:  2005-12-12       Impact factor: 9.079

6.  Knowledge of evidence-based urinary catheter care practice recommendations among healthcare workers in nursing homes.

Authors:  Lona Mody; Sanjay Saint; Andrzej Galecki; Shu Chen; Sarah L Krein
Journal:  J Am Geriatr Soc       Date:  2010-07-19       Impact factor: 5.562

7.  Risk factors for new detection of vancomycin-resistant enterococci in acute-care hospitals that employ strict infection control procedures.

Authors:  Alexander A Padiglione; Rory Wolfe; Elizabeth A Grabsch; Di Olden; Stephen Pearson; Clare Franklin; Denis Spelman; Barrie Mayall; Paul D R Johnson; M Lindsay Grayson
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

8.  Multidrug-resistant gram-negative bacteria in a long-term care facility: prevalence and risk factors.

Authors:  Aurora Pop-Vicas; Susan L Mitchell; Ruth Kandel; Robert Schreiber; Erika M C D'Agata
Journal:  J Am Geriatr Soc       Date:  2008-06-28       Impact factor: 5.562

9.  Trends and significance of VRE colonization in the ICU: a meta-analysis of published studies.

Authors:  Panayiotis D Ziakas; Rachana Thapa; Louis B Rice; Eleftherios Mylonakis
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

10.  The emerging threat of multidrug-resistant gram-negative organisms in long-term care facilities.

Authors:  Erin O'Fallon; Aurora Pop-Vicas; Erika D'Agata
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-01-20       Impact factor: 6.053

View more
  8 in total

Review 1.  Ten-year narrative review on antimicrobial resistance in Singapore.

Authors:  Alvin Qijia Chua; Andrea Lay-Hoon Kwa; Thean Yen Tan; Helena Legido-Quigley; Li Yang Hsu
Journal:  Singapore Med J       Date:  2019-08       Impact factor: 1.858

2.  Epidemiology of Vancomycin-Resistant Enterococcus faecium and Enterococcus faecalis Colonization in Nursing Facilities.

Authors:  Elyse Davis; Liam Hicks; Ihsan Ali; Elizabeth Salzman; Joyce Wang; Evan Snitkin; Kristen Gibson; Marco Cassone; Lona Mody; Betsy Foxman
Journal:  Open Forum Infect Dis       Date:  2020-01-06       Impact factor: 3.835

3.  Budget impact analysis of routinely using whole-genomic sequencing of six multidrug-resistant bacterial pathogens in Queensland, Australia.

Authors:  Louisa G Gordon; Thomas M Elliott; Brian Forde; Brett Mitchell; Philip L Russo; David L Paterson; Patrick N A Harris
Journal:  BMJ Open       Date:  2021-02-01       Impact factor: 2.692

4.  Prevalence and risk factors of colonisation with vancomycin-resistant Enterococci faecium upon admission to Germany's largest university hospital.

Authors:  Minh Trang Bui; Anna M Rohde; Frank Schwab; Nayana Märtin; Marina Kipnis; Anne-Cathérine Boldt; Michael Behnke; Luisa A Denkel; Axel Kola; Janine Zweigner; Petra Gastmeier; Miriam Wiese-Posselt
Journal:  GMS Hyg Infect Control       Date:  2021-01-29

Review 5.  Antibiotic resistance modifying ability of phytoextracts in anthrax biological agent Bacillus anthracis and emerging superbugs: a review of synergistic mechanisms.

Authors:  Mackingsley Kushan Dassanayake; Teng-Jin Khoo; Jia An
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-12-02       Impact factor: 3.944

6.  Genomic surveillance of antimicrobial resistant bacterial colonisation and infection in intensive care patients.

Authors:  Kelly L Wyres; Jane Hawkey; Mirianne Mirčeta; Louise M Judd; Ryan R Wick; Claire L Gorrie; Nigel F Pratt; Jill S Garlick; Kerrie M Watson; David V Pilcher; Steve A McGloughlin; Iain J Abbott; Nenad Macesic; Denis W Spelman; Adam W J Jenney; Kathryn E Holt
Journal:  BMC Infect Dis       Date:  2021-07-14       Impact factor: 3.090

7.  Evaluation of the Association Between Gastric Acid Suppression and Risk of Intestinal Colonization With Multidrug-Resistant Microorganisms: A Systematic Review and Meta-analysis.

Authors:  Roel P J Willems; Karin van Dijk; Johannes C F Ket; Christina M J E Vandenbroucke-Grauls
Journal:  JAMA Intern Med       Date:  2020-04-01       Impact factor: 21.873

8.  Risk factors for vancomycin-resistant enterococcus acquisition during a large outbreak in patients aged 65 years and older.

Authors:  Benjamin Mathis; Max Haïne; Raphaële Girard; Marc Bonnefoy
Journal:  BMC Geriatr       Date:  2019-12-27       Impact factor: 3.921

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.